Adjuvant therapy for breast cancer is any treatment given after primary treatment to increase the chance of long-term survival. This may can include chemotherapy, radiotherapy or hormonal therapy.
Adjuvant therapy for breast cancer is any treatment given after primary treatment to increase the chance of long-term survival. This may can include chemotherapy, radiotherapy or hormonal therapy.
Name | Drug Class | Updated |
---|---|---|
Epirubicin | Antibiotics / antineoplastics | 16-Aug-2023 |
Neratinib | EGFR inhibitors | 14-Aug-2023 |
Trastuzumab | HER2 inhibitors | 12-Aug-2023 |
Tamoxifen | Hormones / antineoplastics | 12-Aug-2023 |
Paclitaxel | Mitotic inhibitors | 11-Aug-2023 |
Leuprolide | Gonadotropin releasing hormones | 11-Aug-2023 |
Letrozole | Aromatase inhibitors | 11-Aug-2023 |
Soltamox | Hormones / antineoplastics | 05-Aug-2023 |
Trazimera | HER2 inhibitors | 14-Jul-2023 |
Taxol | Mitotic inhibitors | 14-Jul-2023 |
Onxol | Mitotic inhibitors | 13-Jul-2023 |
Ontruzant | HER2 inhibitors | 13-Jul-2023 |
Ogivri | HER2 inhibitors | 13-Jul-2023 |
Kanjinti | Drugs | 13-Jul-2023 |
Herzuma | HER2 inhibitors | 13-Jul-2023 |
Ellence | Antibiotics / antineoplastics | 13-Jul-2023 |
Nerlynx | EGFR inhibitors | 11-Jul-2023 |
Herceptin | HER2 inhibitors | 10-Jul-2023 |
Femara | Aromatase inhibitors | 10-Jul-2023 |